Loading market dashboard
Evelo Biosciences, Inc.
EVLOHealthcareOTCUS
Loading disclosure news
News and disclosures filtered by period, publisher, and event group.
Select a headline to open the full news page in the app.
Evelo Biosciences, Inc. (NASDAQ: EVLO - Get Free Report) was the recipient of unusually large options trading on Wednesday. Investors acquired 1,885 put options on the stock. This represents an increase of 1,101% compared to the average volume of 157 put options. Evelo Biosciences Stock Performance Evelo Biosciences has a 1 year low of $0.00 and
Profitability This table compares Silverback Therapeutics and Evelo Biosciences' net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets Silverback Therapeutics N/A -29.62% -28.20% Evelo Biosciences N/A N/A N/A Valuation and Earnings This table compares Silverback Therapeutics and Evelo Biosciences"s top-line revenue, earnings per share (EPS) and valuation.
